Полиморфизм генов рецепторов врожденного иммунитета у новорожденных с гипоксически-ишемическим поражением ЦНС

1. Boskabadi H, Moradi A, Zakerihamidi M. Interleukins in diagnosis of perinatal asphyxia: A systematic review. Int J Reprod Biomed (Yazd). 2018; 17 (5): 303–314. doi: 10.18502/ijrm.v17i5.4598

2. Xiong LL, Xue LL, Al-Hawwas M, Huang J, Niu RZ [et al.] Single-nucleotide polymorphism screening and RNA sequencing of key messenger RNAs associated with neonatal hypoxic-ischemia brain damage. Neural Regen Res. 2020; 15: 86–95. https://www.nrronline.org/text.asp?2020/15/1/86/264469

3. Mottahedin A, Svedin P, Nair S, Mohn CJ, Wang X. [et al.] Systemic activation of Toll-like receptor 2 suppresses mitochondrial respiration and exacerbates hypoxic-ischemic injury in the developing brain. J Cereb Blood Flow Metab. 2017; 37 (4): 1192–1198. doi: 10.1177/0271678X17691292

4. El-Zayat SR, Sibaii H, Mannaa FA. Toll-like receptors activation, signaling, and targeting: an overview. Bull Natl Res Cent. 2019; 43: 187. doi: 10.1186/s42269-019-0227-2

5. Fukui R, Murakami Y, Miyake K. New application of anti-TLR monoclonal antibodies: detection, inhibition and protection. Inflamm Regener. 2018; 38: 11. doi: 10.1186/s41232-018-0068-7

6. Hamann L, Koch A, Sur S, Hoefer N, Glaeser C. [et al.] Association of a common TLR-6 polymorphism with coronary artery disease — implications for healthy ageing? Immun. Ageing. 2013; 10 (1): 43. doi: 10.1186/1742-4933-10-43

7. Барычева ЛЮ, Идрисова АС, Кузьмина ЕС, Агранович ОВ. Клиническое значение провоспалительных интерлейкинов у новорожденных с гипоксически-ишемическим поражением ЦНС. Медицинский вестник Северного Кавказа. 2021; 16 (3): 310–312. doi: 10.14300/mnnc.2021.16074